InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
6
T+90 hit rate
50%
T+90 mean return
+3.5%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Weinberg Eric, Directeur Commercial. Director active across 1 company, notably RxSight, Inc.. Aggregated, 10 reports have been recorded. Split: 4 buys · 6 sells. Total volume traded: €2.9m. Activity tracked since 3 August 2021. The latest transaction was disclosed on 1 February 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
10,000 shares@ US$50.000415.9% of flowCommon StockSEC:0000950170-24-010564:0
10,000 shares@ US$48.000615.1% of flowCommon StockSEC:0000950170-24-006199:0
10,000 shares@ US$46.0014.4% of flowCommon StockSEC:0000950170-24-003681:0
10,000 shares@ US$42.0013.1% of flowCommon StockSEC:0000950170-24-003342:0
1,285 shares@ US$40.001.6% of flowCommon StockSEC:0001209191-23-059682:0
8,715 shares@ US$40.012710.9% of flowCommon StockSEC:0001209191-23-059280:0
210 shares@ US$16.93770.0013% mcap0.4% of flowCommon StockSEC:0000899243-21-031996:0
Ideal exit: 26 Apr 2022 (T+270)
210 shares@ US$16.93770.1% of flowCommon StockSEC:0000899243-21-031996
Ideal exit: 26 Apr 2022 (T+270)
31,250 shares@ US$16.000.18% mcap49.6% of flowCommon StockSEC:0000899243-21-031821:0
Ideal exit: 30 Apr 2022 (T+270)
31,250 shares@ US$16.0014.4% of flowCommon StockSEC:0000899243-21-031821
Ideal exit: 30 Apr 2022 (T+270)
10 of 10 declarations
About Weinberg Eric
Eric Weinberg is the Chief Commercial Officer at RxSight, Inc. He oversees commercial activities and develops strategies to increase revenue. His expertise is crucial for RxSight's growth.
